top of page

Lund based BioInvent has had a busy week with a presentation of one program in ovarian cancer at ASCO, and two more coming up in hematological cancers at the upcoming EHA Congress

Jun 9
1 min read

Chief Scientific Officer Björn Frendéus walks us through the companies antibody discovery platform, and the two lead clinical assets, which target TNFR2 and FcγRIIB.






Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page